Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Schedule
Home
Poster Schedule
All Days
Mon, Oct 21
Tue, Oct 22
Wed, Oct 23
Poster Schedule
Type here to filter the list
Tuesday, October 22, 2024
9:30 AM – 10:30 AM
MT
(T0930-01-01) Capsugel® Enprotect® Capsules Filled with Fecal Microbiota Transplant Placebo Formulation Keep Their Enteric Performance after Six Month Storage at -80°C
Favorite
9:30 AM – 10:30 AM
MT
(T0930-01-03) Intracellular Drug Delivery by Discrete Multiwalled Carbon Nanotubes for MDR Cancer Treatment
Favorite
9:30 AM – 10:30 AM
MT
(T0930-01-04) Impact of Penetration Enhancers on Salbutamol Permeation Across Murine Skin
Favorite
9:30 AM – 10:30 AM
MT
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Favorite
9:30 AM – 10:30 AM
MT
(T0930-01-06) Combatting
Pseudomonas aeruginosa
Biofilms: A Strategy with Glutathione-Conjugated Hydrogels for Disruption and Biofouling Mitigation
Favorite
9:30 AM – 10:30 AM
MT
(T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
Favorite
9:30 AM – 10:30 AM
MT
(T0930-02-08) The Influence of Silica Nanoparticles with Varied Physicochemical Properties on the Immune Function of RAW 264.7 Macrophages
Favorite
9:30 AM – 10:30 AM
MT
(T0930-02-09) Development of Dihydromyricetin for Effective Oral Dosing
Favorite
9:30 AM – 10:30 AM
MT
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Favorite
9:30 AM – 10:30 AM
MT
(T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
Favorite
9:30 AM – 10:30 AM
MT
(T0930-02-12) A PBPK Model to Simulate Intranasal Naloxone Rescue from Fentanyl Overdose
Favorite
9:30 AM – 10:30 AM
MT
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Favorite
9:30 AM – 10:30 AM
MT
(T0930-03-14) Toward Enhanced Solubility of Cannabidiol: Preparation and Evaluation of Cannabidiol Solid Dispersions Using Vacuum Compression Molding and Cryogenic Milling
Favorite
9:30 AM – 10:30 AM
MT
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Favorite
9:30 AM – 10:30 AM
MT
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Favorite
9:30 AM – 10:30 AM
MT
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Favorite
9:30 AM – 10:30 AM
MT
(T0930-03-18) Targeting Multiple Oncogenic Drivers in NSCLC: Therapeutic Potential of ARV-825 and Gefitinib-Based PROTAC-3 Protein Degraders
Favorite
9:30 AM – 10:30 AM
MT
(T0930-04-19) Gemcitabine/Doxorubicin-Combination Polymer-Drug Conjugate Synthesized by SPAAC Click Chemistry: Characterization and Evaluation in OVCAR-3 Ovarian Cancer Cells
Favorite
9:30 AM – 10:30 AM
MT
(T0930-04-20) Effect of Processing Method on Release Profile of Fenofibrate Amorphous Solid Dispersion Prepared by Hot Melt Extrusion and 3D Printing
Favorite
9:30 AM – 10:30 AM
MT
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Favorite
9:30 AM – 10:30 AM
MT
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Favorite
9:30 AM – 10:30 AM
MT
(T0930-04-23) Poly(Acrylic Acid)/Poly(Vinyl Alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
Favorite
9:30 AM – 10:30 AM
MT
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Favorite
9:30 AM – 10:30 AM
MT
(T0930-05-25) Impact of Excipient Types and Drug Loadings on the Tabletability Flip Phenomenon
Favorite
9:30 AM – 10:30 AM
MT
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Favorite
9:30 AM – 10:30 AM
MT
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Favorite
9:30 AM – 10:30 AM
MT
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Favorite
9:30 AM – 10:30 AM
MT
(T0930-05-29) Pulmonary Delivery of mRNA via Engineered Chitosan Nanoparticles: Development and Application
Favorite
9:30 AM – 10:30 AM
MT
(T0930-05-30) Formulation Development and Optimization of Fenofibrate Nanosuspension Coated Microcrystalline Cellulose Based Granules
Favorite
9:30 AM – 10:30 AM
MT
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Favorite
9:30 AM – 10:30 AM
MT
(T0930-06-32) Tumor Chip to Study Dynamics between Immunotherapeutics, Tumor Stroma, and Immune Cells
Favorite
9:30 AM – 10:30 AM
MT
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Favorite
9:30 AM – 10:30 AM
MT
(T0930-06-34) Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA
Favorite
9:30 AM – 10:30 AM
MT
(T0930-06-35) Analysis of Drug-Antibody Ratio (DAR) of ADC (M9346A-SPDB-DM4) in Rabbit Cornea and K
2
EDTA Plasma Using SEC-MS
Favorite
9:30 AM – 10:30 AM
MT
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Favorite
9:30 AM – 10:30 AM
MT
(T0930-07-37) Development of Novel In Vitro Dissolution Assembly for Dissolving Microneedles via 3D Printed Mould - ImprintoGel
Favorite
9:30 AM – 10:30 AM
MT
(T0930-07-38) Understanding Dibasic Calcium Phosphate Impact on Chemical Stability - Trends in Immediate Release Tablet Formulations
Favorite
9:30 AM – 10:30 AM
MT
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Favorite
9:30 AM – 10:30 AM
MT
(T0930-07-40) Soft Foods as Alternative Reconstitution Vehicles for Sodium Oxybate Extended-Release Drug Product (LUMRYZ
TM
)
Favorite
9:30 AM – 10:30 AM
MT
(T0930-07-41) Pulmonary Delivery of Trametinib-Encapsulated Nanostructured Lipid Carriers for Non-Small Cell Lung Cancer
Favorite
9:30 AM – 10:30 AM
MT
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Favorite
9:30 AM – 10:30 AM
MT
(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions
Favorite
9:30 AM – 10:30 AM
MT
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
Favorite
9:30 AM – 10:30 AM
MT
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Favorite
9:30 AM – 10:30 AM
MT
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Favorite
9:30 AM – 10:30 AM
MT
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Favorite
9:30 AM – 10:30 AM
MT
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Favorite
9:30 AM – 10:30 AM
MT
(T0930-10-57) Predicting Pharmacokinetic Response of Small Molecules in Rats via Machine Learning
Favorite
9:30 AM – 10:30 AM
MT
(T0930-10-59) In Vitro and In Vivo Correlations of Danazol-SEDDS Formulations Using MacroFLUX
TM
and miniFLUX™
Favorite
9:30 AM – 10:30 AM
MT
(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor
Favorite
9:30 AM – 10:30 AM
MT
(T0930-11-61) Elevating Liposomal Formulation Analysis: An Advanced CE-C4D Method for Quantification of Ionic Excipients in Liposomal Doxorubicin
Favorite
9:30 AM – 10:30 AM
MT
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Favorite
9:30 AM – 10:30 AM
MT
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Favorite
9:30 AM – 10:30 AM
MT
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Favorite
9:30 AM – 10:30 AM
MT
(T0930-11-65) Quantitative Prediction of Segregation Risk in Multicomponent Pharmaceutical Blends
Favorite
10:30 AM – 11:30 AM
MT
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Favorite
10:30 AM – 11:30 AM
MT
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Favorite
10:30 AM – 11:30 AM
MT
(T1030-01-03) Chitosan DNA Nanoparticle for PRPF31 Gene Delivery in Retinal Cell Line: Formulation and Characterization
Favorite
10:30 AM – 11:30 AM
MT
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Favorite
10:30 AM – 11:30 AM
MT
(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection
Favorite
10:30 AM – 11:30 AM
MT
(T1030-01-06) The Influence of Nanostructural Characteristics on Gene Transfection: Enhanced DNA Delivery Through Macropinocytosis and Efficient Dissociation by Large, Botryoid-Shaped Nanoparticles
Favorite
10:30 AM – 11:30 AM
MT
(T1030-02-07) Pediatric Oral Cavity PBPK Model to Predict Pharmacokinetics of Mucoadhesive Atropine Gel to Treat Sialorrhea
Favorite
10:30 AM – 11:30 AM
MT
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Favorite
10:30 AM – 11:30 AM
MT
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Favorite
10:30 AM – 11:30 AM
MT
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Favorite
10:30 AM – 11:30 AM
MT
(T1030-02-12) Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing
Favorite
10:30 AM – 11:30 AM
MT
(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization
Favorite
10:30 AM – 11:30 AM
MT
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Favorite
10:30 AM – 11:30 AM
MT
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Favorite
10:30 AM – 11:30 AM
MT
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Favorite
10:30 AM – 11:30 AM
MT
(T1030-03-18) Optimization of Antibody Based Products Stabilized within a Film Matrix for Nasal Administration
Favorite
10:30 AM – 11:30 AM
MT
(T1030-04-19) Cannabidiol and BDNF-Encapsulated Brain-Targeted Lipid Nanoparticles Reduce Inflammation, Lower Pathological Amyloid and Tau Levels, and Improve Cognition in Transgenic Models of Alzheimer’s disease
Favorite
10:30 AM – 11:30 AM
MT
(T1030-04-20) Impact of Freeze-Thaw Cycles on Kolliphor P407's Thermogelling and Mucoadhesion
Favorite
10:30 AM – 11:30 AM
MT
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Favorite
10:30 AM – 11:30 AM
MT
(T1030-04-22) Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Favorite
10:30 AM – 11:30 AM
MT
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Favorite
10:30 AM – 11:30 AM
MT
(T1030-04-24) Oren-gedoku-to, a Traditional Chinese Medicine, Prevents the Hyperglycemia Caused by Chronic Olanzapine Administration via Hypothalamic AMP-Activated Protein Kinase Activity
Favorite
10:30 AM – 11:30 AM
MT
(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics
Favorite
10:30 AM – 11:30 AM
MT
(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
Favorite
10:30 AM – 11:30 AM
MT
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Favorite
10:30 AM – 11:30 AM
MT
(T1030-05-28) Characterizing the Effects of a Novel Surfactant on Growth Inhibition and Preservation of Different Bacterial Species
Favorite
10:30 AM – 11:30 AM
MT
(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle
Favorite
10:30 AM – 11:30 AM
MT
(T1030-05-30) Moisture Sorption of Microcrystalline Cellulose
Favorite
10:30 AM – 11:30 AM
MT
(T1030-06-33) Development of Novel Cis-Receptor Occupancy Method for Bispecific Antibodies
Favorite
10:30 AM – 11:30 AM
MT
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Favorite
10:30 AM – 11:30 AM
MT
(T1030-06-36) Liquid Chromatography – Tandem Mass Spectrometry for Quantification of Zymostenol and Lathosterol in Human Serum with High Specificity and Low Background Noise
Favorite
10:30 AM – 11:30 AM
MT
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Favorite
10:30 AM – 11:30 AM
MT
(T1030-07-38) SubQ Environment Impact on In Vitro Drug Release of PLGA Microspheres
Favorite
10:30 AM – 11:30 AM
MT
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
Favorite
10:30 AM – 11:30 AM
MT
(T1030-07-40) New Direct Compressible Mannitol for Minitablets Industrial Scale Manufacturing
Favorite
10:30 AM – 11:30 AM
MT
(T1030-07-41) Development of N-Salsalate Parenteral Nanosuspension: A Safe and Effective Analgesic for Post-Operative Pain Management
Favorite
10:30 AM – 11:30 AM
MT
(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Favorite
10:30 AM – 11:30 AM
MT
(T1030-09-49) Analyzing the Characteristics of HME Extruded Material in Pharmaceutical 3D Printing: Formulation, Printability, and Dissolution Study
Favorite
10:30 AM – 11:30 AM
MT
(T1030-09-50) Amorphous Solid Dispersions of Spray Dried Celecoxib-SBE7βCD-Polymer Ternary Complexes: Enhancements on Intrinsic Dissolution, Crystallization Prevention, and Stabilizing Effects.
Favorite
10:30 AM – 11:30 AM
MT
(T1030-09-51) Simplification Study of Feed System in HPMCAS Dry Coating
Favorite
10:30 AM – 11:30 AM
MT
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Favorite
10:30 AM – 11:30 AM
MT
(T1030-10-54) Development of Dual-Ligand Nanoparticles for Systemic Chemoimmunotherapy of Cancer
Favorite
10:30 AM – 11:30 AM
MT
(T1030-10-55) Development of Vaginal Thermosensitive Hydrogel for Enhanced Local Progesterone Delivery
Favorite
10:30 AM – 11:30 AM
MT
(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity
Favorite
10:30 AM – 11:30 AM
MT
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Favorite
10:30 AM – 11:30 AM
MT
(T1030-10-58) Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
Favorite
10:30 AM – 11:30 AM
MT
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Favorite
10:30 AM – 11:30 AM
MT
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Favorite
10:30 AM – 11:30 AM
MT
(T1030-11-61) Comprehensive Composition Analysis of Doxorubicin HCl Liposomes
Favorite
10:30 AM – 11:30 AM
MT
(T1030-11-62) Impacts of Method Conditions and Autosampler Characteristics on Method Migration
Favorite
10:30 AM – 11:30 AM
MT
(T1030-11-63) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants
Favorite
10:30 AM – 11:30 AM
MT
(T1030-11-64) Mechanistic Prediction of Tablet Breaking Force for Binary Blends Based on Individual Component Properties
Favorite
10:30 AM – 11:30 AM
MT
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Favorite
11:30 AM – 12:30 PM
MT
(T1130-01-01) Active Targeting to the Hepatocytes: How Important is Tailoring the Liposomes and Physicochemical Properties and Surface Modification in Targeting the Hepatocytes?
Favorite
11:30 AM – 12:30 PM
MT
(T1130-01-02) Application of Knowledge Based Expert System to Predict API-Excipient Incompatibilities
Favorite
11:30 AM – 12:30 PM
MT
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Favorite
11:30 AM – 12:30 PM
MT
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Favorite
11:30 AM – 12:30 PM
MT
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Favorite
11:30 AM – 12:30 PM
MT
(T1130-01-06) Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against
Candida albicans
Favorite
11:30 AM – 12:30 PM
MT
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Favorite
11:30 AM – 12:30 PM
MT
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Favorite
11:30 AM – 12:30 PM
MT
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Favorite
11:30 AM – 12:30 PM
MT
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Favorite
11:30 AM – 12:30 PM
MT
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Favorite
11:30 AM – 12:30 PM
MT
(T1130-02-12) Idasanutlin-Ionizable Lipid Nanocomplex (IDLIN) for Enhanced Solubility, Stability, and Anticancer Activity in p53 Sensitive Lung Cancer
Favorite
11:30 AM – 12:30 PM
MT
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
Favorite
11:30 AM – 12:30 PM
MT
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel
®
RC-591 Rheological Performance in Suspensions
Favorite
11:30 AM – 12:30 PM
MT
(T1130-03-16) Rational Design of Viscosity-Reducing Formulation Compositions for High-Concentration Protein Solutions
Favorite
11:30 AM – 12:30 PM
MT
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Favorite
11:30 AM – 12:30 PM
MT
(T1130-03-18) Leveraging Prior Knowledge for Drug Product Development: A Streamlined Lab-Scale Process Characterization Study Approach
Favorite
11:30 AM – 12:30 PM
MT
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Favorite
11:30 AM – 12:30 PM
MT
(T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
Favorite
11:30 AM – 12:30 PM
MT
(T1130-04-21) Plasmid ApoE2 Gene Delivery Across the Blood Brain Barrier for the Treatment of Alzheimer's Disease
Favorite
11:30 AM – 12:30 PM
MT
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Favorite
11:30 AM – 12:30 PM
MT
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Favorite
11:30 AM – 12:30 PM
MT
(T1130-04-24) Automated Workflow for Targeted Protein Degrader (TPD) Metabolite Identification Using Collision-Induced Dissociation (CID) and Electron-Activated Dissociation (EAD)
Favorite
11:30 AM – 12:30 PM
MT
(T1130-05-25) Hyper-Oxygenating Respiratoid Biosystem for Cell Transplantation
Favorite
11:30 AM – 12:30 PM
MT
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Favorite
11:30 AM – 12:30 PM
MT
(T1130-05-27) Bioequivalence Recommendations for Tretinoin-Containing Topical Products
Favorite
11:30 AM – 12:30 PM
MT
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Favorite
11:30 AM – 12:30 PM
MT
(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site
Favorite
11:30 AM – 12:30 PM
MT
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Favorite
11:30 AM – 12:30 PM
MT
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Favorite
11:30 AM – 12:30 PM
MT
(T1130-06-33) Investigating the Modelability of Human Oral Fraction Absorbed using Regulatory Data
Favorite
11:30 AM – 12:30 PM
MT
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Favorite
11:30 AM – 12:30 PM
MT
(T1130-06-35) Leveraging Machine Learning to Predict Clinical Adverse Events Driven by Target-Specific and Off-Target Binding
Favorite
11:30 AM – 12:30 PM
MT
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Favorite
11:30 AM – 12:30 PM
MT
(T1130-07-37) Albumin Corona Improves Colloidal Stability of Nanosac, a Non-Cationic Polyphenol Gene Carrier
Favorite
11:30 AM – 12:30 PM
MT
(T1130-07-38) Deformable Polydopamine Nanocapsules for siRNA Delivery to Solid Tumors
Favorite
11:30 AM – 12:30 PM
MT
(T1130-07-39) Development of Novel Combination Therapy containing Lobeglitazone and Its Clinical Studies in Patients with Poorly Controlled Type 2 Diabetes
Favorite
11:30 AM – 12:30 PM
MT
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Favorite
11:30 AM – 12:30 PM
MT
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Favorite
11:30 AM – 12:30 PM
MT
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Favorite
11:30 AM – 12:30 PM
MT
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Favorite
11:30 AM – 12:30 PM
MT
(T1130-09-50) Biopharmaceutical Tools for De-risking Paediatric Formulation Development
Favorite
11:30 AM – 12:30 PM
MT
(T1130-09-51) Accelerating SEDDS Formulation Development with Machine Learning
Favorite
11:30 AM – 12:30 PM
MT
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Favorite
11:30 AM – 12:30 PM
MT
(T1130-09-53) Smart Formulating of Pharmaceutical Emulsions Using HLD-NAC Theory
Favorite
11:30 AM – 12:30 PM
MT
(T1130-10-54) Developing Robust Control Strategies for an Unexpected Fluorination Process Investigation
Favorite
11:30 AM – 12:30 PM
MT
(T1130-10-55) Physicochemical Stability Investigation of Insulin in a Mesoporous Carrier Used for Oral Delivery
Favorite
11:30 AM – 12:30 PM
MT
(T1130-10-56) Understanding Friability Performance in Titanium-Free Film Coated Tablets as a Function of Tablet Shape and Core Composition
Favorite
11:30 AM – 12:30 PM
MT
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
Favorite
11:30 AM – 12:30 PM
MT
(T1130-10-58) Effective Product Life-Cycle Management Through Continued Process Verification (Stage 3) Using Statistical Software
Favorite
11:30 AM – 12:30 PM
MT
(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex
Favorite
11:30 AM – 12:30 PM
MT
(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles
Favorite
11:30 AM – 12:30 PM
MT
(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality
Favorite
11:30 AM – 12:30 PM
MT
(T1130-11-63) Optical Radiocarbon (
14
C) Tracing for Biological and Pharmaceutical Applications
Favorite
11:30 AM – 12:30 PM
MT
(T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug
Favorite
11:30 AM – 12:30 PM
MT
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Favorite
12:30 PM – 1:30 PM
MT
(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System
Favorite
12:30 PM – 1:30 PM
MT
(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics
Favorite
12:30 PM – 1:30 PM
MT
(T1230-01-03) A High Oral Bioavailable Berberine-Lornoxicam Cocrystal with Improved Caco-2 Permeability, Tunable Dissolution, and Improved Taste
Favorite
12:30 PM – 1:30 PM
MT
(T1230-01-04) Development and Characterization of Solid Lipid Nanoparticles Encapsulating Curcumin for Targeted Therapy of Mucosal-Barrier Associated Cancers
Favorite
12:30 PM – 1:30 PM
MT
(T1230-01-05) Polymeric Micelles for Nose-to-Brain Delivery of Rapamycin
Favorite
12:30 PM – 1:30 PM
MT
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Favorite
12:30 PM – 1:30 PM
MT
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Favorite
12:30 PM – 1:30 PM
MT
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Favorite
12:30 PM – 1:30 PM
MT
(T1230-02-09) Examination of the Diffusion Properties of Hydrogels as Optimized Preclinical In Vitro Models for the Human Vitreous Body
Favorite
12:30 PM – 1:30 PM
MT
(T1230-02-10) Revisiting Potency Classification of Topical Corticosteroids Using a Standardized Approach Involving Vasoconstrictor Assay (VCA)
Favorite
12:30 PM – 1:30 PM
MT
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Favorite
12:30 PM – 1:30 PM
MT
(T1230-02-12) Gaps in Non-Binary Populations in Clinical Trial Participation: A Comparative Analysis of Cardiovascular and Solid Tumor Studies
Favorite
12:30 PM – 1:30 PM
MT
(T1230-03-13) Enhancement of Transdermal Delivery for β-Carotene as a Treatment of Skin Cancer: Quality by Design Optimization of Microemulsion Formulation
Favorite
12:30 PM – 1:30 PM
MT
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
Favorite
12:30 PM – 1:30 PM
MT
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Favorite
12:30 PM – 1:30 PM
MT
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Favorite
12:30 PM – 1:30 PM
MT
(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
Favorite
12:30 PM – 1:30 PM
MT
(T1230-03-18) Targeting Brain Metastasis in Non-Small Cell Lung Cancer with EGFRT790M Mutation Using BBB-Penetrating Codelivery Liposomes
Favorite
12:30 PM – 1:30 PM
MT
(T1230-04-19) Novel Targeted Drug and Metabolites Mapping Using DESI MRM Triple Quadrupole Mass Spectrometer Providing Increased Sensitivity and Acquisition Speed for Mass Spectrometry Imaging
Favorite
12:30 PM – 1:30 PM
MT
(T1230-04-20) Mechanism of Curcumin Encapsulation by GCPQ Polymers: Unexpected Polymer Mesh (Matrix) Configuration Revealed by Atomistic Molecular Dynamics Simulations
Favorite
12:30 PM – 1:30 PM
MT
(T1230-04-21) Synthesis and Characterization of Multi-Functionalized Chitosan Polymeric Micelles for Intranasal Delivery of pApoE2 to PS19 Tauopathy Mice
Favorite
12:30 PM – 1:30 PM
MT
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Favorite
12:30 PM – 1:30 PM
MT
(T1230-04-23) PBPK Modeling to Predict the Effect of Gastric pH on Bioequivalence of Dabigatran Etexilate Capsules
Favorite
12:30 PM – 1:30 PM
MT
(T1230-04-24) SPE-LC/MS Bioanalytical Quantification of the Biotherapeutic Peptide, Semaglutide from Plasma
Favorite
12:30 PM – 1:30 PM
MT
(T1230-05-25) How are Medicines Administered to Pre-school Children? Current Status of a Global Survey on the Use of Dosing Vehicles
Favorite
12:30 PM – 1:30 PM
MT
(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs
Favorite
12:30 PM – 1:30 PM
MT
(T1230-05-27) Impact of Polymer Residual Content on the Quality Characteristics of Risperidone PLGA Microspheres
Favorite
12:30 PM – 1:30 PM
MT
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Favorite
12:30 PM – 1:30 PM
MT
(T1230-05-30) Controlled Release Mannose and RVG-9R Functionalized PLGA Nanoparticles for Targeting the Brain Viral Reservoir for the Management of HIV Associated Neurocognitive Disorder
Favorite
12:30 PM – 1:30 PM
MT
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Favorite
12:30 PM – 1:30 PM
MT
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Favorite
12:30 PM – 1:30 PM
MT
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Favorite
12:30 PM – 1:30 PM
MT
(T1230-06-34) PEGylated Nanoparticles Conjugated with LHRH Receptor Binding Peptide for Treatment of Lung Cancer
Favorite
12:30 PM – 1:30 PM
MT
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Favorite
12:30 PM – 1:30 PM
MT
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Favorite
12:30 PM – 1:30 PM
MT
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Favorite
12:30 PM – 1:30 PM
MT
(T1230-07-40) Evaluating the Gastric Integrity of Capsugel® Enprotect® Capsules in Fasted and Fed State Using the Dynamic Gastric Model (DGM)
Favorite
12:30 PM – 1:30 PM
MT
(T1230-07-41) Assessing the Impact of Cryo-Freezing in Different Topical Formulations
Favorite
12:30 PM – 1:30 PM
MT
(T1230-09-48) Development of Dissolving Microneedles for Delivery of Semaglutide for Treatment of Type 2 Diabetes and Obesity
Favorite
12:30 PM – 1:30 PM
MT
(T1230-09-49) Complex of Paclitaxel Mesoporous Silica Nanoparticles with Curcumin, TPGS Exerts Higher Anticancer Potency in B16F10 Melanoma
Favorite
12:30 PM – 1:30 PM
MT
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
Favorite
12:30 PM – 1:30 PM
MT
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Favorite
12:30 PM – 1:30 PM
MT
(T1230-09-52) Exploring Particle Behaviour during Dissolution Testing of Long-Acting Injectable Suspensions - A Potential Role for Image Analysis
Favorite
12:30 PM – 1:30 PM
MT
(T1230-09-53) Development of siRNA Incorporated PEGylated and Polysorbate 80 Coated Polymeric Nanoparticles for Global Cerebral Ischemia
Favorite
12:30 PM – 1:30 PM
MT
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Favorite
12:30 PM – 1:30 PM
MT
(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying
Favorite
12:30 PM – 1:30 PM
MT
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Favorite
12:30 PM – 1:30 PM
MT
(T1230-10-57) Biorelevant Dissolution Testing in Tiny-TIMsg to Improve Predictivity of Food Effect on Oral Delivery of BCS Class II Compound
Favorite
12:30 PM – 1:30 PM
MT
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Favorite
12:30 PM – 1:30 PM
MT
(T1230-10-59) Elucidation of Drug Release Mechanisms of Quetiapine Fumarate Extended-Release Tablets Via Real Time Surface Dissolution Imaging
Favorite
12:30 PM – 1:30 PM
MT
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Favorite
12:30 PM – 1:30 PM
MT
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
Favorite
12:30 PM – 1:30 PM
MT
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Favorite
12:30 PM – 1:30 PM
MT
(T1230-11-63) Laser Directed Infrared (LDIR) Imaging to Track the Evolution of Polymorphic Transformation During Stability Studies on Ritonavir Tablets
Favorite
12:30 PM – 1:30 PM
MT
(T1230-11-64) Roller Compaction Simulation Reproducible Milling Technologies Between Lab Scale and Pilote Scale
Favorite
12:30 PM – 1:30 PM
MT
(T1230-11-65) Epinephrine Degradation in Pediatric Auto-Injectors
Favorite
1:30 PM – 12:30 PM
MT
(T1330-06-33) Ultra-High Throughput HILIC-Free Analysis of Oligonucleotides Using Acoustic Ejection Mass Spectrometry
Favorite
1:30 PM – 2:30 PM
MT
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Favorite
1:30 PM – 2:30 PM
MT
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Favorite
1:30 PM – 2:30 PM
MT
(T1330-01-03) Development of Hypoxia-Responsive Polymersomes for Drug Delivery to Pancreatic Ductal Adenocarcinoma (PDAC) Cells
Favorite
1:30 PM – 2:30 PM
MT
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
Favorite
1:30 PM – 2:30 PM
MT
(T1330-01-06) A Novel Liposome Delivering Adavosertib for Ovarian Cancer Treatment
Favorite
1:30 PM – 2:30 PM
MT
(T1330-02-07) Translational PK/PD Modeling to Predict Human PK and Treg Depletion of a Monoclonal Antibody Based on Preclinical Data
Favorite
1:30 PM – 2:30 PM
MT
(T1330-02-08) Machine Learning Approaches for Assessing Medication Transfer to Human Breast Milk: Estimating Milk/Plasma Drug Ratios
Favorite
1:30 PM – 2:30 PM
MT
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Favorite
1:30 PM – 2:30 PM
MT
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix
Puerariae lobatae
in Healthy Subjects
Favorite
1:30 PM – 2:30 PM
MT
(T1330-02-11) A PBPK Model for Acetaminophen: Incorporation of SULT Enzyme Ontogeny to Predict Age-Dependent Metabolism and Systemic Exposure in Pediatric Patient Populations
Favorite
1:30 PM – 2:30 PM
MT
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Favorite
1:30 PM – 2:30 PM
MT
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
Favorite
1:30 PM – 2:30 PM
MT
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Favorite
1:30 PM – 2:30 PM
MT
(T1330-03-17) Developing Biosustane SAIB NF as a Novel Excipient for Oral Dosage Forms
Favorite
1:30 PM – 2:30 PM
MT
(T1330-03-18) Taking Medicines the Milky Way: How Does Milk Affect Disintegration of Mini-Tablets with a Taste-Masking Coating?
Favorite
1:30 PM – 2:30 PM
MT
(T1330-04-19) Non-Gelatin Film Coatings for Formulating Easy-to-Swallow Tablets
Favorite
1:30 PM – 2:30 PM
MT
(T1330-04-20) Unveiling the Potential of
Euterpe oleraceae
Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Favorite
1:30 PM – 2:30 PM
MT
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Favorite
1:30 PM – 2:30 PM
MT
(T1330-04-22) Exploring the Synergistic Potential of Fatty Acid Synthase Inhibitors and Geranylgeranyl Diphosphate Synthase Inhibitors in Myeloma Therapy
Favorite
1:30 PM – 2:30 PM
MT
(T1330-04-23) Concurrent Effect of Lipids and Surfactants on Intestinal Drug Absorption: A Modeling Approach
Favorite
1:30 PM – 2:30 PM
MT
(T1330-05-26) Development and Characterization of Dose Flexible Printlets of Lamivudine Using Binder Jet – 3D Printing
Favorite
1:30 PM – 2:30 PM
MT
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Favorite
1:30 PM – 2:30 PM
MT
(T1330-05-29) Selection of Excipients for Levodopa-Loaded Microparticles Prepared Using Spray-Drying
Favorite
1:30 PM – 2:30 PM
MT
(T1330-05-30) Permeability Enhancer Incorporated Oral Nano-Suspension of BRD4 Degrader for Glioblastoma Treatment
Favorite
1:30 PM – 2:30 PM
MT
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Favorite
1:30 PM – 2:30 PM
MT
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Favorite
1:30 PM – 2:30 PM
MT
(T1330-06-34) LC-MS/MS Method for the Quantitation of Each Monoclonal Antibody (from a 6-Components Antibody Cocktail Drug Product) in Human Serum Matrix
Favorite
1:30 PM – 2:30 PM
MT
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
Favorite
1:30 PM – 2:30 PM
MT
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Favorite
1:30 PM – 2:30 PM
MT
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Favorite
1:30 PM – 2:30 PM
MT
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Favorite
1:30 PM – 2:30 PM
MT
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Favorite
1:30 PM – 2:30 PM
MT
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Favorite
1:30 PM – 2:30 PM
MT
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Favorite
1:30 PM – 2:30 PM
MT
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Favorite
1:30 PM – 2:30 PM
MT
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Favorite
1:30 PM – 2:30 PM
MT
(T1330-09-52) Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer
Favorite
1:30 PM – 2:30 PM
MT
(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step
Favorite
1:30 PM – 2:30 PM
MT
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Favorite
1:30 PM – 2:30 PM
MT
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Favorite
1:30 PM – 2:30 PM
MT
(T1330-10-59) High Shear Wet Granulation Scale-Up Using Basic Principles
Favorite
1:30 PM – 2:30 PM
MT
(T1330-11-60) Flow Imaging Microscopy for Monitoring Subvisible and Submicron Particles in Cell and Gene Therapies
Favorite
1:30 PM – 2:30 PM
MT
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Favorite
1:30 PM – 2:30 PM
MT
(T1330-11-62) Laboratory Study in Gastric Nitrosamine Formation
Favorite
1:30 PM – 2:30 PM
MT
(T1330-11-63) Developing a Risk Score for Critical Suppliers Using Artificial Intelligence (AI)
Favorite
1:30 PM – 2:30 PM
MT
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Favorite
1:30 PM – 2:30 PM
MT
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
Favorite
2:30 PM – 3:30 PM
MT
(T1430-01-01) Preparation of a Modified Release Dosage Form of Diltiazem Hydrochloride Using Cation Exchange Resins
Favorite
2:30 PM – 3:30 PM
MT
(T1430-01-02) Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy
Favorite
2:30 PM – 3:30 PM
MT
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
Favorite
2:30 PM – 3:30 PM
MT
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Favorite
2:30 PM – 3:30 PM
MT
(T1430-01-05) Formulation Development of Novel PLGA-Based Long-Acting Monolithic Implant
Favorite
2:30 PM – 3:30 PM
MT
(T1430-01-06) Preparation and Characterization of Diclofenac Loaded Polymeric Nanoparticles from Mango Seed Kernel Starch
Favorite
2:30 PM – 3:30 PM
MT
(T1430-02-07) Exploring the Potential Influence of Physicochemical Characteristics on Biodistribution of Iron-Carbohydrate Nanoparticles Using a Chicken Embryo Model
Favorite
2:30 PM – 3:30 PM
MT
(T1430-02-08) Ontogeny of Drug Metabolizing Enzymes and Its Impact on Valproic Acid Hepatotoxicity: Insights from In Vitro and PBPK Modeling Studies
Favorite
2:30 PM – 3:30 PM
MT
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Favorite
2:30 PM – 3:30 PM
MT
(T1430-02-10) Modified Dissolution-Permeation Assembly Mimicking In Vivo Condition: An Ideal Method to Test Dissolution Profile of Nanosuspension Formulation
Favorite
2:30 PM – 3:30 PM
MT
(T1430-02-11) Alcohol Dose Dumping in Modified Release Formulations: Critical Considerations for Regulatory Guidance(s)
Favorite
2:30 PM – 3:30 PM
MT
(T1430-02-12) Ocular Pharmacokinetic Model for Intravitreal Antibody Injection
Favorite
2:30 PM – 3:30 PM
MT
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Favorite
2:30 PM – 3:30 PM
MT
(T1430-03-14) Delivery of mRNA-LNP Vaccine via Refrigerator-Stable Microneedle Array Patch
Favorite
2:30 PM – 3:30 PM
MT
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Favorite
2:30 PM – 3:30 PM
MT
(T1430-03-16) Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections
Favorite
2:30 PM – 3:30 PM
MT
(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease
Favorite
2:30 PM – 3:30 PM
MT
(T1430-03-18) Balancing Particle Stability and Permeability Advantages of High Drug Loading Amorphous Nanoparticle Formulations
Favorite
2:30 PM – 3:30 PM
MT
(T1430-04-20) In Situ Engineering of Tumor-Infiltrating Myeloid Cells Through Dendrimer-Based Lipid Nanoparticles
Favorite
2:30 PM – 3:30 PM
MT
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Favorite
2:30 PM – 3:30 PM
MT
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Favorite
2:30 PM – 3:30 PM
MT
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Favorite
2:30 PM – 3:30 PM
MT
(T1430-04-24) Method Optimization to Reduce Leakage of Encapsulated Protein from Ethylcellulose Microcapsules Using Bovine Serum Albumin as a Model Protein
Favorite
2:30 PM – 3:30 PM
MT
(T1430-05-25) Monitoring the Dissolution Behavior of Dissolving Microneedles by UV-Vis Imaging System
Favorite
2:30 PM – 3:30 PM
MT
(T1430-05-26) Lipid Nanoparticle Impurity Analysis: Leveraging Mass Spectrometry to Monitor Impurities and Aldehyde in Raw Materials and Formulated Drugs in Regulated Environments
Favorite
2:30 PM – 3:30 PM
MT
(T1430-05-27) Evaluate pH-Triggered and Sustainable Drug Release for Dendrimer-Based Formulations of STAT3 Inhibitor
Favorite
2:30 PM – 3:30 PM
MT
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Favorite
2:30 PM – 3:30 PM
MT
(T1430-05-29) Critical System Suitability Test Established in Regulatory Analytical Procedures for Testing Organic Impurities in Drug Substance and Drug Product and Relevant Changes in Recently Revised USP
Favorite
2:30 PM – 3:30 PM
MT
(T1430-05-30) Preparation and Characterization of Nanoemulsion Formulation for Andrographolide to Improve its Oral Bioavailability Characteristics
Favorite
2:30 PM – 3:30 PM
MT
(T1430-06-31) Automated Supporting Liquid Extraction (SLE) Workflow to Extract Zolmitriptan from Plasma Samples for Bioanalysis
Favorite
2:30 PM – 3:30 PM
MT
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Favorite
2:30 PM – 3:30 PM
MT
(T1430-06-33) Comparison of the Pharmacokinetics and Metabolic Fate of Gefitinib – 3 – PROTACs and Gefitinib in the Rat Following Subcutaneous Dosing
Favorite
2:30 PM – 3:30 PM
MT
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Favorite
2:30 PM – 3:30 PM
MT
(T1430-06-36) Addressing Target Interference During the Development of a Neutralizing Anti-Drug Antibody Assay for the Clinical Support of a Bispecific Therapeutic Antibody
Favorite
2:30 PM – 3:30 PM
MT
(T1430-07-38) Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with Folate Receptor-α (FRα) Ligand, Pemetrexed
Favorite
2:30 PM – 3:30 PM
MT
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Favorite
2:30 PM – 3:30 PM
MT
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Favorite
2:30 PM – 3:30 PM
MT
(T1430-09-48) Exploring Mannitol's Influence on Protein Stability: Spray-Dried rHGH Formulations
Favorite
2:30 PM – 3:30 PM
MT
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
Favorite
2:30 PM – 3:30 PM
MT
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Favorite
2:30 PM – 3:30 PM
MT
(T1430-09-51) Feasibility of Controlled Nitric Oxide Generation via Ascorbate Induced Chemical Reduction of Nitrite Ions
Favorite
2:30 PM – 3:30 PM
MT
(T1430-09-52) Encorafenib and Trametinib Co-Loaded Nanoparticles as a Therapy for Colon Cancer
Favorite
2:30 PM – 3:30 PM
MT
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Favorite
2:30 PM – 3:30 PM
MT
(T1430-10-55) Manual 2D LC-MS for Peak Purity Assessment of Atropisomeric Compound
Favorite
2:30 PM – 3:30 PM
MT
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Favorite
2:30 PM – 3:30 PM
MT
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck
®
SLC through Z-Form Binder Jetting Technology
Favorite
2:30 PM – 3:30 PM
MT
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on
N
‑Nitrosamine Formation
Favorite
2:30 PM – 3:30 PM
MT
(T1430-10-59) Enhanced Versatility of a Novel Coating Methods of Fine Particles for Time-Saving
Favorite
2:30 PM – 3:30 PM
MT
(T1430-11-60) Determining Impact of Particle Size and Crystal Quality on Formation of Nitrosamine in API and Drug Formulations
Favorite
2:30 PM – 3:30 PM
MT
(T1430-11-61) Predictive Residence Time Distribution Models for Continuous Powder Blending
Favorite
2:30 PM – 3:30 PM
MT
(T1430-11-62) What Is That Peak in Hydrocodone Bitartrate USP Reference Standard?
Favorite
2:30 PM – 3:30 PM
MT
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Favorite
2:30 PM – 3:30 PM
MT
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Favorite
2:30 PM – 3:30 PM
MT
(T1430-11-65) Unraveling the Impact of Polymeric Material Attributes in Semisolid Products: Paving the Way for Consistent Viscosity Profile Across Commercial Batches
Favorite
3:30 PM – 4:30 PM
MT
(T1530-01-01) Proven New Sustainable Eco-Friendly Packaging for Challenging Formulation Compositions
Favorite
3:30 PM – 4:30 PM
MT
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Favorite
3:30 PM – 4:30 PM
MT
(T1530-01-03) Influence of Composition Variation on Solubility and Release Profile of CBD Self-Emulsifying Drug Delivery System
Favorite
3:30 PM – 4:30 PM
MT
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Favorite
3:30 PM – 4:30 PM
MT
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Favorite
3:30 PM – 4:30 PM
MT
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Favorite
3:30 PM – 4:30 PM
MT
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Favorite
3:30 PM – 4:30 PM
MT
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Favorite
3:30 PM – 4:30 PM
MT
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Favorite
3:30 PM – 4:30 PM
MT
(T1530-02-11) Prediction of Lacosamide Concentrations to Optimize Dosing during Pregnancy
Favorite
3:30 PM – 4:30 PM
MT
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Favorite
3:30 PM – 4:30 PM
MT
(T1530-03-13) Delineating the Effect of Commonly Used Surfactant/Cosurfactant Compositions Affecting the Dispersion Characteristics of Aqueous-Based Nasal Sprays
Favorite
3:30 PM – 4:30 PM
MT
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Favorite
3:30 PM – 4:30 PM
MT
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Favorite
3:30 PM – 4:30 PM
MT
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
Favorite
3:30 PM – 4:30 PM
MT
(T1530-03-18) Physicochemical Characterization and In Vitro/Ex Vivo Evaluation of Transdermal Gels of Baricitinib for Rheumatoid Arthritis
Favorite
3:30 PM – 4:30 PM
MT
(T1530-04-19) Lymphatic Targeting of Cyclosporine Improves Survival and Ameliorates Lupus-Like Autoimmune Disease in NZB/W Mice
Favorite
3:30 PM – 4:30 PM
MT
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Favorite
3:30 PM – 4:30 PM
MT
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Favorite
3:30 PM – 4:30 PM
MT
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Favorite
3:30 PM – 4:30 PM
MT
(T1530-04-23) Constitution of a Helical Peptide on Exosome-Mimetic Vesicles
Favorite
3:30 PM – 4:30 PM
MT
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Favorite
3:30 PM – 4:30 PM
MT
(T1530-06-31) Discovery of Potassium Channel K
v
7.4(KCNQ4) Selective Activator for the Treatment of Hearing loss
Favorite
3:30 PM – 4:30 PM
MT
(T1530-06-33) PAR-1 Selective Antagonist, SCH-79797 Dihydrochloride, Inhibits the Proliferation and Migration of the Metastatic Human Prostate Cancer (PC-3) Cells
Favorite
3:30 PM – 4:30 PM
MT
(T1530-06-34) Ion-pairing Agent-Free SFC Separation of Polypeptides Using Automated Method Development Tools
Favorite
3:30 PM – 4:30 PM
MT
(T1530-06-35) Effect of Vasculotropic Dutch Amyloid Beta 40 on Blood-Brain Barrier (BBB) Endothelial Trafficking and Signaling
Favorite
3:30 PM – 4:30 PM
MT
(T1530-06-36) DoE-Based Optimization of RNA Nanosac Lyophilization for Cold-Chain-Free Storage and Transportation
Favorite
3:30 PM – 4:30 PM
MT
(T1530-07-37) Direct Compression and Continuous Wet Granulation for Controlled Release Minitablets
Favorite
3:30 PM – 4:30 PM
MT
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Favorite
3:30 PM – 4:30 PM
MT
(T1530-07-39) Overcoming Incompatibility between Moxifloxacin and Carbopol
®
934 Polymers in Ophthalmic Drug Delivery Systems
Favorite
3:30 PM – 4:30 PM
MT
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Favorite
3:30 PM – 4:30 PM
MT
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese
TM
for Long-Acting Implants
Favorite
3:30 PM – 4:30 PM
MT
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Favorite
3:30 PM – 4:30 PM
MT
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Favorite
3:30 PM – 4:30 PM
MT
(T1530-09-50) Development of an In Vitro Release Test to Characterize Onivyde Using Bio-Beads SM-2 Resin
Favorite
3:30 PM – 4:30 PM
MT
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Favorite
3:30 PM – 4:30 PM
MT
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Favorite
3:30 PM – 4:30 PM
MT
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Favorite
3:30 PM – 4:30 PM
MT
(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry
Favorite
3:30 PM – 4:30 PM
MT
(T1530-10-55) 3D Printed Container System for Delayed Release
Favorite
3:30 PM – 4:30 PM
MT
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Favorite
3:30 PM – 4:30 PM
MT
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Favorite
3:30 PM – 4:30 PM
MT
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Favorite
3:30 PM – 4:30 PM
MT
(T1530-11-60) Evaluation of Near Infrared (NIR) for the Quantitation of Low Dose Drugs
Favorite
3:30 PM – 4:30 PM
MT
(T1530-11-61) Advanced Characterization of COVID-19 mRNA Vaccines Using Litesizer DLS Instruments
Favorite
3:30 PM – 4:30 PM
MT
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Favorite
3:30 PM – 4:30 PM
MT
(T1530-11-63) Development of the USP Chapter for Solid-State Nuclear Magnetic Resonance Spectroscopy
Favorite
3:30 PM – 4:30 PM
MT
(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing
Favorite
3:30 PM – 4:30 PM
MT
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Favorite
